The drug was particularly effective in breast cancers with a mutation in the ESR1 gene, which encodes estrogen receptors, ...

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

First-in-human results for three investigational inhibitors show anti-tumor activity without unmanageable effects on blood glucose.

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

Dr. Michael Koehler, Medical Director at Affinity Whole Health, offers tips ahead of the holiday season. VALLEY VIEW, OH / ACCESSWIRE / December 13, 2024 / As we approach the 2024 holiday season, a ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling ...

Hope S. Rugo, MD, FASCO, discusses how the combination of elacestrant and abemaciclib compares with other treatment options for patients with advanced breast cancer, whether estrogen receptor-positive ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

The U S House of Representatives passed a defense funding bill Wednesday that would prohibit military healthcare plans from ...